Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Depreciation & Amortization - Total (2020 - 2025)

INVO Fertility has reported Depreciation & Amortization - Total over the past 6 years, most recently at $31391.0 for Q3 2025.

  • Quarterly Depreciation & Amortization - Total rose 20.18% to $31391.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $120291.0 through Sep 2025, up 25.7% year-over-year, with the annual reading at $102103.0 for FY2024, 27.11% up from the prior year.
  • Depreciation & Amortization - Total was $31391.0 for Q3 2025 at INVO Fertility, roughly flat from $31378.0 in the prior quarter.
  • Over five years, Depreciation & Amortization - Total peaked at $31391.0 in Q3 2025 and troughed at $2431.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization - Total is $20504.0 (2023), against an average of $19043.9.
  • Year-over-year, Depreciation & Amortization - Total surged 789.39% in 2022 and then dropped 8.9% in 2023.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $11432.0 in 2021, then soared by 70.47% to $19488.0 in 2022, then grew by 7.91% to $21029.0 in 2023, then surged by 30.46% to $27435.0 in 2024, then rose by 14.42% to $31391.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Depreciation & Amortization - Total are $31391.0 (Q3 2025), $31378.0 (Q2 2025), and $30087.0 (Q1 2025).